Tetrandrine Tablets Used in Hospitalized Adults With COVID-19

Summary

The primary objective of this study is to evaluate the effectiveness of tetrandrine tablets in preventing the progression of COVID-19 from severe to critical.

Timeline

Start

2023-12-31

Primary completion

2025-12-12

Completion

2025-12-12

Outcome

Outcome not reported

Stopped (Business): “Due to the lack of funding from the sponsor, the research drug and placebo cannot be obtained.”

Drugs

Indications